Artificial intelligence to explore and combat eukaryotic pathogens

人工智能探索和对抗真核病原体

• 批准号: LP220200614
• 负责人: Prof Robin Gasser
• 金额: $ 58.36万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2023
• 资助国家: 澳大利亚
• 起止时间: 2023-07-01 至 2026-06-30
• 项目状态: 未结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP220200614
• 关键词: Artificial; intelligence; explore; combat; eukaryotic

The revolution in artificial intelligence (AI) provides unprecedented opportunities for integrative analyses of complex multi-omics data sets and for creating radically new strategies to control some of the world’s most serious animal diseases. In a strong partnership with international experts, we will use AI-based methods to make major conceptual advances in our understanding of eukaryotic pathogens and host-pathogen interactions, discover the "choke-points" in biological pathways, and develop novel treatments, vaccines and diagnostics. This leap forward will substantially enhance the global profile of pathogen research in Australia, build major capacity in a priority area, and enable access to international research funding and networks.

人工智能（AI）的革命为复杂的多组学数据集的综合分析提供了前所未有的机会，并为控制世界上一些最严重的动物疾病创造了全新的策略。在与国际专家的强有力合作中，我们将使用基于人工智能的方法，在我们对真核病原体和宿主-病原体相互作用的理解方面取得重大概念性进展，发现生物途径中的“瓶颈”，并开发新的治疗方法，疫苗和诊断方法。这一飞跃将大大提高澳大利亚病原体研究的全球形象，在优先领域建立主要能力，并使其能够获得国际研究资金和网络。